Harry Skip Kiil, an insider at Medtronic plc (MDT), sold a significant block of shares on February 26, 2026. The transaction involved 30,568 shares valued at $97.66 each, resulting in a total sale of approximately $2,985,270.
This sale follows a series of other transactions by Mr. Kiil on February 19, 2026, which also involved the sale of Medtronic shares. While insider selling can occur for various reasons, including personal financial planning and diversification, it is noteworthy given the aggregate value of the recent dispositions.
Medtronic plc operates as a global leader in medical technology, developing and manufacturing a wide range of innovative medical devices and therapies. The company's products are used to treat patients in various therapeutic areas, including cardiac and vascular diseases, diabetes, and neurological disorders.